Daniel Billen
Presidente en AURINIA PHARMACEUTICALS INC. .
Fortuna: 137 047 $ al 30/04/2024
Cargos activos de Daniel Billen
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Independent Dir/Board Member | 29/04/2019 | - |
| Presidente | 18/08/2023 | - | |
| Director/Miembro de la Junta | 29/04/2019 | 18/08/2023 |
Historial de carrera de Daniel Billen
Antiguos cargos conocidos de Daniel Billen.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/01/2011 | 01/01/2018 |
Amgen Canada, Inc.
 Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 01/01/1991 | 01/01/2011 |
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Ventas & Marketing | 01/01/1979 | 01/01/1991 |
Formación de Daniel Billen.
| Université Catholique de Louvain | Doctorate Degree |
Estadísticas
Internacional
| Canadá | 4 |
| Estados Unidos | 2 |
| Bélgica | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chairman | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Amgen Canada, Inc. operates as a biotechnology company. The company was founded in 1991 and is headquartered in Mississauga, Canada. | Health Technology |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Daniel Billen
- Experiencia
